- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for Probiotec Ltd (PG3)
| Open: | 0.231 | Day's Range: | 0.231 - 0.231 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.230 | 52wk Range: | 0.164 - 0.343 | 1-Yr Rtn: | +20.31% |
Key Statistics for PG3
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (06/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (AUD) | - |
| Last Dividend | 02/26/2011 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PG3
Company Profile & Key Executives for PG3
Probiotec Ltd. manufactures over-the-counter pharmaceuticals and complementary products. The Company also contract manufactures prescription, over-the-counter, and neutraceutical products for third parties.
| Charles Wayne StringerCEO/Managing Director | Alan HongChief Financial Officer |
| Jared StringerCFO/Secretary | Wesley StringerChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PG3 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page